Naphthoflavone propargyl ether inhibitors of cytochrome P450

被引:7
|
作者
Zhu, Naijue
Lightsey, Danielle
Foroozesh, Maryam
Alworth, William
Chaudhary, Amit
Willett, Kristine L.
Stevens, Cheryl L. Klein [1 ]
机构
[1] Xavier Univ Louisiana, Dept Chem, New Orleans, LA 70125 USA
[2] Tulane Univ, Dept Chem, New Orleans, LA 70118 USA
[3] Univ Mississippi, Dept Pharmacol, Mississippi State, MS USA
[4] Univ Mississippi, Environm Toxicol Res Program, Sch Pharm, Mississippi State, MS USA
关键词
naphthoflavone propargyl ether; P450; inhibitors; X-ray crystal structures;
D O I
10.1007/s10870-005-9061-5
中图分类号
O7 [晶体学];
学科分类号
0702 ; 070205 ; 0703 ; 080501 ;
摘要
Cytochrome P450 enzymes protect the body from foreign substances through a mechanism that involves oxidation of those substances into more readily excretable polar compounds. It has been shown that some naphthoflavones function as substrates of certain P450 enzymes (CYP1A1 and CYP1B1) and with appropriate structural changes may become inhibitors. Moreover, propargyl ether derivatives of adamantane have been shown to function as selective inactivators of some P450 enzymes (CYP2B1 and CYP2B5). In an attempt to improve the potency and selectivity of inhibition, we have designed and synthesized a series of naphthoflavone propargyl ethers. We report here the synthesis, X-ray crystal structures, and inhibition data (IC50 of EROD inhibition in CYP1A1 and CYP1B1 enzymes) of alpha-naphthoflavone 2-propargyl ether, beta-naphthoflavone 2'-propargyl ether, alpha-naphthoflavone 4-propargyl ether, and beta-naphthoflavone 4'-propargyl ether. Crystallographic data: alpha-naphthoflavone 2'-propargyl ether, P (1) over bar, a=7.775(1) angstrom, b=8.062(1) angstrom, c=13.110(1) angstrom, alpha = 84.32(1)degrees, beta = 75.42(1)degrees, gamma = 86.56(1)degrees, V=790.8(2)angstrom(3); beta-naphthoflavone 2'-propargyl ether, P (1) over bar, a = 7.605(2) angstrom, b = 7.793(1) angstrom, c = 14.167(2) angstrom, alpha = 77.06(1)degrees, beta = 75.41(1)degrees, gamma = 89.54(1)degrees, V = 790.9(2) angstrom(3); alpha-naphthoflavone 4'-propargyl ether, P21/n, a = 14.595(2) angstrom, b=4.708(1) angstrom, c=24.745(6) angstrom, beta=106.31(2)degrees, V=1631.8(7) angstrom(3); beta-naphthoflavone 4'-propargyl ether, P1, a=4.8871(5) angstrom, b = 7.9597(7) angstrom, c=21.788(3) angstrom, alpha = 81.771(9)degrees, beta = 89.918(10)degrees, gamma = 72.223(8)degrees, V = 797.9(2) angstrom(3).
引用
收藏
页码:289 / 296
页数:8
相关论文
共 50 条
  • [21] Cytochrome P450
    Poulos, TL
    CURRENT OPINION IN STRUCTURAL BIOLOGY, 1995, 5 (06) : 767 - 774
  • [22] Cytochrome p450 recognition sites for NADPH cytochrome p450 reductase
    Dai, R
    Robinson, RC
    Friedman, FK
    BIOPHYSICAL JOURNAL, 1996, 70 (02) : SU162 - SU162
  • [23] Measurement of cytochrome P450 and NADPH-cytochrome P450 reductase
    Guengerich, F. Peter
    Martin, Martha V.
    Sohl, Christal D.
    Cheng, Qian
    NATURE PROTOCOLS, 2009, 4 (09) : 1245 - 1251
  • [24] Analysis of Heterotropic Cooperativity in Cytochrome P450 3A4 Using α-Naphthoflavone and Testosterone
    Frank, Daniel J.
    Denisov, Ilia G.
    Sligar, Stephen G.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (07) : 5540 - 5545
  • [25] Cytochrome P450 inhibitors attenuate myocardial reperfusion injury
    Granville, DJ
    Tashakkor, B
    Takeuchi, C
    Gustafsson, ÅB
    Sayen, MR
    Yeager, M
    Wentworth, P
    Gottlieb, RA
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2003, 35 (06) : A16 - A16
  • [26] Isothiocyanate flavones as inhibitors of human cytochrome P450 enzymes
    Dotson, Brandan
    Lovings, La'Nese
    Liu, Jiawang
    Foroozesh, Maryam
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 247
  • [27] A patent review on the development of human cytochrome P450 inhibitors
    Francis, Sheena
    Delgoda, Rupika
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2014, 24 (06) : 699 - 717
  • [28] Acute effect of cytochrome P450 inhibitors on pressure natriuresis
    Sarkis, AG
    Lopez, B
    Roman, RJ
    FASEB JOURNAL, 2004, 18 (05): : A1037 - A1037
  • [29] Ethynyl flavones as inhibitors of human cytochrome P450 enzymes
    Taylor, Shannon F.
    Liu, Jiawang
    Dupart, Patrick
    Foroozesh, Maryam
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 245
  • [30] Pharmacokinetics and pharmacodynamics of cytochrome P450 inhibitors for HIV treatment
    Gong, Yuqing
    Haque, Sanjana
    Chowdhury, Pallabita
    Cory, Theodore J.
    Kodidela, Sunitha
    Yallapu, Murali M.
    Norwood, John M.
    Kumar, Santosh
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2019, 15 (05) : 417 - 427